Robyn Temple-Smolkin

Senior Director, Clinical & Scientific Affairs; Director, Guideline Development at @AMPath. MBA, PhD, HCLD(ABB). Tweets are my own; RTs ≠ endorsements

[Eric K. Singhi, MD @lungoncdoc]

🔥 NGS isn’t underused due to lack of data. It’s underused because reports are HARD to use.

▫️@AMPath @Pathologists consensus: Only 1/17 NSCLC reports were oncologist-friendly.
▫️The fix: Standardized, guideline-aligned reporting.

🔗 https://t.co/Juoc6vLIDn

[Robyn Temple-Smolkin @Robyn_Temple]

Hello #Boston...it's been awhile #AMPath2025

[Robyn Temple-Smolkin @Robyn_Temple]

Not an April Fool's post - see you in Boston! #AMPath2025 @AMPath #beantown

[Association for Molecular Pathology @AMPath]

Today's the day! We're now accepting abstracts for the AMP 2025 Annual Meeting & Expo (#AMPath2025) in Boston in November.

Submit by June 30 to be considered for a platform and/or poster presentation.

Here's the info you need: https://t.co/94HXzxdtyS

[Association for Molecular Pathology @AMPath]

🚨 Big news: The U.S. District Court has ruled in our favor, thwarting the FDA’s attempt to impose excessive regulations on laboratory-developed testing procedures (LDTs). This is a win for labs, patients and innovation! Ruling and opinion: https://t.co/IAR5vheLQX

[Association for Molecular Pathology @AMPath]

Today's the last day to secure early-bird pricing on our live online Molecular Genetic Pathology Review Course in May! This course will include lectures, case studies, live Q&A sessions and in-depth discussions. Learn more and register: https://t.co/kSXcTVsppa

[Association for Molecular Pathology @AMPath]

We're at @TheUSCAP's annual meeting this weekend! Swing by booth 1004 to meet our membership manager, Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of @AMPath can mean for you. #USCAP2025

[Association for Molecular Pathology @AMPath]

At our AMP Middle East meeting in Abu Dhabi, Somak Roy (@roysomak4)will give two presentations, one about what clinical bioinformaticians need to know and one about in silico resources for NGS bioinformatics pipeline validation.

See all speakers: https://t.co/2kZCsPXaYy

[Association for Molecular Pathology @AMPath]

We're going to be at @TheUSCAP's annual meeting this weekend! Swing by booth 1004 to meet our membership manager, Jocelyn Friedrich; get your hands on some "Molecular in My Pocket" reference cards; and find out what being a member of @AMPath can mean for you. #USCAP2025

[Association for Molecular Pathology @AMPath]

🔬 Dive into #bioinformatics challenges with our "Next-Generation Bioinformatics" certificate program! This online training examines complex genomic anomalies in NGS testing. 🌟 Members save 25%! Enroll ➡️ https://t.co/Fd0XbGIYAI

[Robyn Temple-Smolkin @Robyn_Temple]

Happy Pi Day!

[Association for Molecular Pathology @AMPath]

We convened a working group to update the guideline for classification, annotation, interpretation and reporting of somatic sequence variants published in 2017. The working group seeks comments on its draft recommendations. Read them and submit a comment: https://t.co/2o7eM0e7e9

[Robyn Temple-Smolkin @Robyn_Temple]

Happy to share I'm now an @ASAEcenter Certified Association Executive (CAE)! Congratulations to all who received their new credential today!

[National Institute of Standards and Technology @NIST]

NIST has developed a reference material to support the production of diagnostic tests for the bird flu (H5N1). This nonhazardous genetic material will enhance the nation’s response to outbreaks of disease and ensure companies’ quality control. Read more: https://t.co/z2woKKINDx

[Robyn Temple-Smolkin @Robyn_Temple]

Help support @AMPath volunteers working with @AJCCancer to provide #precisionmedicine expertise supporting best practices for #oncology #patientcare? Now there’s a New Year’s resolution I’m happy to keep!

[ACS Cancer Programs @AmColSurgCancer]

The Association for Molecular Pathology (AMP) has recently joined the @AJCCancer as a new member organization. The AMP advances clinical practice, science, and excellence of molecular and genomic laboratory medicine. Welcome, @AMPath!

[Association for Molecular Pathology @AMPath]

Free webinar on Jan. 30: "Germline Testing in Cancer Patients: Molecular Diagnostic Considerations
and Clinical Implications." It'll feature speaker Diana Mandelker of @MSKCancerCenter and provide continuing-education credit: https://t.co/eagIfE3004

[Robyn Temple-Smolkin @Robyn_Temple]

Looking forward to what 2025 brings!

[Association for Molecular Pathology @AMPath]

One of the top articles in 2024 in @JMDiagn, AMP's official journal:

⭐DPYD Genotyping Recommendations ⭐

https://t.co/sWZ7wUSDzZ

#openaccess

[Association for Molecular Pathology @AMPath]

Not sure what your lab should be doing in light of the FDA's final rule on laboratory-developed testing procedures? We've put together a webpage with a ton of resources to help you at each stage. Check it out and share it with others who need it: https://t.co/TeNpJPK5jT

[Association for Molecular Pathology @AMPath]

.@AMPath is now a member organization of @AJCCancer, which "provides worldwide leadership in the development, promotion and maintenance of evidence-based systems for the classification and management of cancer." https://t.co/04idPLkn40 (cc: @AmColSurgCancer )

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Recommendations for Cell-Free DNA Assay Validations: A Joint Consensus Recommendation of @AMPath and @Pathologists.

Free in the #OpenArchive: https://t.co/b15pblcAIk